Nazli Albayrak
Nazli Albayrak has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Nadiye Koroglu
Kanuni Sultan Suleyman Research and Training Hospital, Department of Obstetrics and Gynecology, Istanbul, Turkey
3 shared publications - Turgut Aydin
Department of Obstetrics and Gynecology Acıbadem Mehmet Ali Aydınlar University Atakent Hospital Istanbul Turkey
2 shared publications - Ayşen Yücetürk
Acıbadem Maslak Hospital, In Vitro Fertilization Center, İstanbul, Türkiye
1 shared publication - Bülent Tıraş
Acıbadem Mehmet Ali Aydınlar University School of Medicine, Department of Obstetrics & Gynecology and Reproductive Endocrinology, İstanbul, Türkiye
1 shared publication Cameron Alexander Nejat
1 shared publication- Edis Kahraman
Department of Obstetrics and Gynecology Acıbadem Mehmet Ali Aydınlar University Atakent Hospital Istanbul Turkey
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (9) , 1581-1590
Progesterone-based ovulation timing versus LH surge monitoring in true natural cycle frozen embryo transfer: impact on live birth rates in a prospective cohort study
STUDY QUESTION: Does progesterone-based embryo transfer timing achieve live birth rates comparable to LH-surge-based timing in true natural cycle frozen embryo transfer (NC-FET)? SUMMARY ANSWER: Progesterone-based embryo transfer timing was associated with live birth rates comparable to those achieved with LH surge-based timing in true NC-FET, with no evidence of an independent association between ovulation timing strategy and live birth after adjustment for potential confounders. WHAT IS KNOWN ALREADY: In true NC-FET, embryo transfer timing is commonly scheduled according to the LH surge. However, identification of the LH surge may be challenging. Serum progesterone rise may reflect ovulation timing, yet its use as an alternative approach for scheduling embryo transfer in NC-FET cycles remains insufficiently investigated. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 490 true NC-FET cycles performed at a single tertiary IVF center between 2022 and 2025. Cycles were analyzed according to the ovulation timing strategy used for embryo transfer scheduling: progesterone-based timing (n = 286) or LH surge-based timing (n = 204). PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovulation was monitored using serial ultrasound and serum hormone measurements. Embryo transfer timing was scheduled according to either detection of the LH surge or the rise in serum progesterone concentrations. The primary outcome was live birth. Adjusted relative risks were estimated using modified Poisson regression with robust standard errors, adjusting for infertility duration and etiology, endometrial thickness at transfer, embryo quality, and number of embryos transferred. Adjusted absolute risk differences were calculated using marginal standardization. An exploratory threshold-based assessment was performed on the risk-difference scale. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth occurred in 162 of 286 progesterone-timed cycles (56.6%) and 106 of 204 LH-timed cycles (52.0%) (unadjusted RR 1.09, 95% CI 0.93–1.28). After adjustment, ovulation timing strategy showed no evidence of an independent association with live birth (adjusted RR 1.09, 95% CI 0.93–1.30; P = 0.264). The adjusted absolute risk difference was +4.9% (95% CI −3.8% to +13.6%). Clinical pregnancy, hCG positivity, and miscarriage rates were also comparable between groups. In exploratory analyses, follicle size measured 1 day before ovulation was positively correlated with progesterone levels on the embryo transfer day (Spearman r = 0.36, P < 0.001), and embryo-transfer-day progesterone levels were positively correlated with estradiol levels measured 1 day before ovulation (Spearman r = 0.29, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The observational design may introduce residual confounding despite statistical adjustment. The timing strategy was not randomized and reflected an evolving institutional protocol. In addition, the progesterone thresholds were derived and applied within a single-center assay environment, which may limit generalizability to other clinical settings and laboratory platforms. WIDER IMPLICATIONS OF THE FINDINGS: Progesterone-based timing may represent a feasible alternative to LH-based scheduling in true NC-FET, although confirmation in adequately powered multicenter studies is required. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.
- 15 July 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (9) , 1581-1590
Open AccessProgesterone-based ovulation timing versus LH surge monitoring in true natural cycle frozen embryo transfer: impact on live birth rates in a prospective cohort study
STUDY QUESTION: Does progesterone-based embryo transfer timing achieve live birth rates comparable to LH-surge-based timing in true natural cycle frozen embryo transfer (NC-FET)? SUMMARY ANSWER: Progesterone-based embryo transfer timing was associated with live birth rates comparable to those achieved with LH surge-based timing in true NC-FET, with no evidence of an independent association between ovulation timing strategy and live birth after adjustment for potential confounders. WHAT IS KNOWN ALREADY: In true NC-FET, embryo transfer timing is commonly scheduled according to the LH surge. However, identification of the LH surge may be challenging. Serum progesterone rise may reflect ovulation timing, yet its use as an alternative approach for scheduling embryo transfer in NC-FET cycles remains insufficiently investigated. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 490 true NC-FET cycles performed at a single tertiary IVF center between 2022 and 2025. Cycles were analyzed according to the ovulation timing strategy used for embryo transfer scheduling: progesterone-based timing (n = 286) or LH surge-based timing (n = 204). PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovulation was monitored using serial ultrasound and serum hormone measurements. Embryo transfer timing was scheduled according to either detection of the LH surge or the rise in serum progesterone concentrations. The primary outcome was live birth. Adjusted relative risks were estimated using modified Poisson regression with robust standard errors, adjusting for infertility duration and etiology, endometrial thickness at transfer, embryo quality, and number of embryos transferred. Adjusted absolute risk differences were calculated using marginal standardization. An exploratory threshold-based assessment was performed on the risk-difference scale. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth occurred in 162 of 286 progesterone-timed cycles (56.6%) and 106 of 204 LH-timed cycles (52.0%) (unadjusted RR 1.09, 95% CI 0.93–1.28). After adjustment, ovulation timing strategy showed no evidence of an independent association with live birth (adjusted RR 1.09, 95% CI 0.93–1.30; P = 0.264). The adjusted absolute risk difference was +4.9% (95% CI −3.8% to +13.6%). Clinical pregnancy, hCG positivity, and miscarriage rates were also comparable between groups. In exploratory analyses, follicle size measured 1 day before ovulation was positively correlated with progesterone levels on the embryo transfer day (Spearman r = 0.36, P < 0.001), and embryo-transfer-day progesterone levels were positively correlated with estradiol levels measured 1 day before ovulation (Spearman r = 0.29, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The observational design may introduce residual confounding despite statistical adjustment. The timing strategy was not randomized and reflected an evolving institutional protocol. In addition, the progesterone thresholds were derived and applied within a single-center assay environment, which may limit generalizability to other clinical settings and laboratory platforms. WIDER IMPLICATIONS OF THE FINDINGS: Progesterone-based timing may represent a feasible alternative to LH-based scheduling in true NC-FET, although confirmation in adequately powered multicenter studies is required. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.
- Open Access
- 17 March 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- p. 1-9
From Gastrulation to Malformation: Understanding the Embryology of Split Cord Malformations for Obstetric Practice
Background: Split cord malformation (SCM) is an uncommon congenital anomaly in which the spinal cord is longitudinally divided into two hemicords separated by a fibrous, cartilaginous, or osseous septum. Historically described as diastematomyelia or diplomyelia, the unified classification proposed by Pang et al. [Neurosurgery. 1992;31(3):451–80] distinguishes two main subtypes: type I, characterized by two hemicords within separate dural sacs divided by a rigid spur, and type II, in which hemicords share a single dural sac separated by a fibrous band. Composite SCM, involving multiple noncontiguous lesions, is exceedingly rare. Summary: Although SCM is most often recognized in childhood following neurological symptoms or cutaneous stigmata, advances in fetal ultrasonography and MRI now permit prenatal diagnosis. This shift carries significant implications for obstetric counseling, delivery planning, and multidisciplinary perinatal care. While surgical correction in infancy remains the mainstay of treatment, the growing ability to detect SCM in utero has prompted discussion of fetal therapy. Unlike open spina bifida, SCM is primarily a tethering disorder rather than a neural tube closure defect, and no evidence currently supports fetal intervention. This review covers the embryology, classification, epidemiology, clinical features, diagnostics, and management of SCM, with emphasis on prenatal imaging, obstetric considerations, and future prospects for fetal therapy. Key Messages: SCM encompasses distinct subtypes defined by dural anatomy and septum composition. Prenatal imaging has transformed antenatal detection, reshaping obstetric and multidisciplinary planning. As a tethering disorder rather than a neural tube defect, SCM does not currently warrant fetal intervention, and postnatal surgical untethering remains the standard of care.
- 17 March 2026
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- p. 1-9
Open AccessFrom Gastrulation to Malformation: Understanding the Embryology of Split Cord Malformations for Obstetric Practice
Background: Split cord malformation (SCM) is an uncommon congenital anomaly in which the spinal cord is longitudinally divided into two hemicords separated by a fibrous, cartilaginous, or osseous septum. Historically described as diastematomyelia or diplomyelia, the unified classification proposed by Pang et al. [Neurosurgery. 1992;31(3):451–80] distinguishes two main subtypes: type I, characterized by two hemicords within separate dural sacs divided by a rigid spur, and type II, in which hemicords share a single dural sac separated by a fibrous band. Composite SCM, involving multiple noncontiguous lesions, is exceedingly rare. Summary: Although SCM is most often recognized in childhood following neurological symptoms or cutaneous stigmata, advances in fetal ultrasonography and MRI now permit prenatal diagnosis. This shift carries significant implications for obstetric counseling, delivery planning, and multidisciplinary perinatal care. While surgical correction in infancy remains the mainstay of treatment, the growing ability to detect SCM in utero has prompted discussion of fetal therapy. Unlike open spina bifida, SCM is primarily a tethering disorder rather than a neural tube closure defect, and no evidence currently supports fetal intervention. This review covers the embryology, classification, epidemiology, clinical features, diagnostics, and management of SCM, with emphasis on prenatal imaging, obstetric considerations, and future prospects for fetal therapy. Key Messages: SCM encompasses distinct subtypes defined by dural anatomy and septum composition. Prenatal imaging has transformed antenatal detection, reshaping obstetric and multidisciplinary planning. As a tethering disorder rather than a neural tube defect, SCM does not currently warrant fetal intervention, and postnatal surgical untethering remains the standard of care.
- Open Access
- 10 March 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (1) , 35-40
Effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study
Effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study - Turkish Journal of Obstetrics and Gynecology
- 10 March 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (1) , 35-40
Open AccessEffects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study
Effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study - Turkish Journal of Obstetrics and Gynecology
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e89
COMPARISON OF PROPOFOL-FENTANYL AND MIDAZOLAM-REMIFENTANIL COMBINATIONS IN OOCYTE PICK-UP PROCEDURE
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e89
COMPARISON OF PROPOFOL-FENTANYL AND MIDAZOLAM-REMIFENTANIL COMBINATIONS IN OOCYTE PICK-UP PROCEDURE
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e301-e302
IMPACT OF FERTILITY PRESERVATION IN GYNECOLOGICAL MALIGNANCIES: ASSESSING INFERTILITY, PREGNANCY OUTCOMES, QUALITY OF LIFE, AND DECISION REGRET FOLLOWING FERTILITY-SPARING SURGERY
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e301-e302
IMPACT OF FERTILITY PRESERVATION IN GYNECOLOGICAL MALIGNANCIES: ASSESSING INFERTILITY, PREGNANCY OUTCOMES, QUALITY OF LIFE, AND DECISION REGRET FOLLOWING FERTILITY-SPARING SURGERY
- 23 June 2023
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 40 (8) , 1897-1903
Serial progesterone levels more accurately predict the time of ovulation in subfertile women: a prospective cohort study
Purpose To predict ovulation in subfertile women using serial follicular growth (FG) and serum hormone measures (estradiol (E2), luteinizing hormone (LH), and progesterone (P) levels) in mathematical models. Methods This was a prospective observational study of 116 subfertile women aged between 18 and 40 years. FG was assessed by serial transvaginal ultrasonography starting from cycle days 8–12, depending on cycle length. Once the dominant follicle reached 15–16 mm, hormone levels were assessed daily. The primary outcome measure was ovulation (Ov), with a serum LH level ≥15 IU/l defining the start of the LH surge (the day prior to ovulation) and a serum P level >1 μg/ml concurrent with a drop in serum E2 levels indicating Ov. To determine Ov, mathematical models were generated using FG, LH, E2, and P measurements. Results A mathematical model was constructed using exponential regression to relate days until and after ovulation with P levels. The Ov(P) model was found to be superior to the Ov(LH) model in the prediction of Ov, with high R2 and low RMSE values of 0.9983 and 0.2454, respectively. In the range of [−2, 2] days, the net accuracy of the Ov(P) model was 63.0%, while with an allowed one-day error, the accuracy was 99.6%. Conclusion Serum P levels display a highly predictable linear curve in natural cycles, which enables the prediction of ovulation. The Ov(P) model can be independently used to schedule embryo transfer in natural frozen-thaw cycles and could therefore replace the Ov(LH) model in clinical practice.
- 23 June 2023
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 40 (8) , 1897-1903
Serial progesterone levels more accurately predict the time of ovulation in subfertile women: a prospective cohort study
Purpose To predict ovulation in subfertile women using serial follicular growth (FG) and serum hormone measures (estradiol (E2), luteinizing hormone (LH), and progesterone (P) levels) in mathematical models. Methods This was a prospective observational study of 116 subfertile women aged between 18 and 40 years. FG was assessed by serial transvaginal ultrasonography starting from cycle days 8–12, depending on cycle length. Once the dominant follicle reached 15–16 mm, hormone levels were assessed daily. The primary outcome measure was ovulation (Ov), with a serum LH level ≥15 IU/l defining the start of the LH surge (the day prior to ovulation) and a serum P level >1 μg/ml concurrent with a drop in serum E2 levels indicating Ov. To determine Ov, mathematical models were generated using FG, LH, E2, and P measurements. Results A mathematical model was constructed using exponential regression to relate days until and after ovulation with P levels. The Ov(P) model was found to be superior to the Ov(LH) model in the prediction of Ov, with high R2 and low RMSE values of 0.9983 and 0.2454, respectively. In the range of [−2, 2] days, the net accuracy of the Ov(P) model was 63.0%, while with an allowed one-day error, the accuracy was 99.6%. Conclusion Serum P levels display a highly predictable linear curve in natural cycles, which enables the prediction of ovulation. The Ov(P) model can be independently used to schedule embryo transfer in natural frozen-thaw cycles and could therefore replace the Ov(LH) model in clinical practice.
- 16 December 2022
- Published by Elsevier in Fertility and Sterility
- Vol. 119 (4) , 705
Correlation of ovarian follicle size with IVF outcomes
- 16 December 2022
- Published by Elsevier in Fertility and Sterility
- Vol. 119 (4) , 705
Correlation of ovarian follicle size with IVF outcomes
- Top Cited PapersOpen Access
- 23 April 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-8
Immersive virtual reality on childbirth experience for women: a randomized controlled trial
Objective: To evaluate the effectiveness of immersive virtual reality (VR) on patient satisfaction as a distractive tool and pain relief among laboring women. Methods: This was a randomized, controlled clinical trial with 42 laboring women allocated to VR intervention and control groups. Among women in the VR group, patient satisfaction with the use of VR was assessed by a Virtual Reality Satisfaction Survey, measured by a Visual Analog Scale (VAS) score and evaluated by questioning them about whether they would choose VR in future labor. As a primary outcome, patient satisfaction scores regarding the overall childbirth experience were compared between women in the two groups. A secondary outcome was pain assessed by a visual pain rating scale in the early and active phases of labor in women in both groups. Psychometric information was also collected from participants in each group using the Beck Anxiety Inventory and Beck Depression Inventory. Results: We observed a high level of patient satisfaction with the use of immersive VR during labor. The VAS revealed a mean satisfaction score of 87.7 ± 12.9 out of a maximum of 100. Twenty out of 21 (95%) women in the VR group stated that they would like to use VR again in future labor. VR improved pain scores in early labor and contributed positively to the overall childbirth experience. The mean pain score pre-VR was 2.6 ± 1.2 compared to 2.0 ± 1.3 post-VR (p < 0.01). Anxiety and depression scores were similar in participants in the intervention and control groups (p = 0.103 and p = 0.13, respectively). Conclusion: Immersive VR application during labor was associated with higher patient satisfaction based on our study findings. VR also improved participants’ pain scores in early labor before epidural administration. Immersive VR may find a place as an adjunct in labor and delivery units to improve lengthy labor experiences for women. Studies with larger groups of participants are needed to confirm these observations. Trial Registration: ClinicalTrials.gov: NCT05032456
- 23 April 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-8
Top Cited PapersOpen AccessImmersive virtual reality on childbirth experience for women: a randomized controlled trial
Objective: To evaluate the effectiveness of immersive virtual reality (VR) on patient satisfaction as a distractive tool and pain relief among laboring women. Methods: This was a randomized, controlled clinical trial with 42 laboring women allocated to VR intervention and control groups. Among women in the VR group, patient satisfaction with the use of VR was assessed by a Virtual Reality Satisfaction Survey, measured by a Visual Analog Scale (VAS) score and evaluated by questioning them about whether they would choose VR in future labor. As a primary outcome, patient satisfaction scores regarding the overall childbirth experience were compared between women in the two groups. A secondary outcome was pain assessed by a visual pain rating scale in the early and active phases of labor in women in both groups. Psychometric information was also collected from participants in each group using the Beck Anxiety Inventory and Beck Depression Inventory. Results: We observed a high level of patient satisfaction with the use of immersive VR during labor. The VAS revealed a mean satisfaction score of 87.7 ± 12.9 out of a maximum of 100. Twenty out of 21 (95%) women in the VR group stated that they would like to use VR again in future labor. VR improved pain scores in early labor and contributed positively to the overall childbirth experience. The mean pain score pre-VR was 2.6 ± 1.2 compared to 2.0 ± 1.3 post-VR (p < 0.01). Anxiety and depression scores were similar in participants in the intervention and control groups (p = 0.103 and p = 0.13, respectively). Conclusion: Immersive VR application during labor was associated with higher patient satisfaction based on our study findings. VR also improved participants’ pain scores in early labor before epidural administration. Immersive VR may find a place as an adjunct in labor and delivery units to improve lengthy labor experiences for women. Studies with larger groups of participants are needed to confirm these observations. Trial Registration: ClinicalTrials.gov: NCT05032456
- 31 December 2020
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 17 (4) , 580-584
Pregnancy Outcomes After Emergency Cerclage For Cervical Insufficiency A Retrospective Study
Aim: Evaluation of maternal and fetal outcomes, effectiveness and reliability of the cerclage for the emergently cerclaged cases due to cervical insufficiency Materials and Methods: Clinical data from live singleton pregnancies who were diagnosed cervical insufficiency were reviewed retrospectively between the Feb 2010-Jan 2019, at Acıbadem University and Mersin University, Department of Obstetrics and Gynecology. Results: During the study period, total 29 cervical cerclage operation was performed by McDonald technique. Mean maternal age 31.82±4.449 years (21–38), mean gestational age at diagnosis and cerclage placement was 22.17±2.071 weeks (18-28). Take home baby rate was 79.3 % (n=23). Mean time interval between the cerclage and the birth is 9.24±5.723 weeks (0-18), mean pregnancy week during the birth is 31.4±5.02 weeks (23-39) and mean birth weight is 1873±903 g (650-3782). There was no surgical complication reported from the studied population. Thirty percent (9) of the patients were delivered by C-section. Discussion: Emergency cerclage prolongs the pregnancy duration of the women with cervical insufficiency, and has marked effects on improving the neonatal outcomes. It is thought to be an appropriate choice for the women with cervical dilatation at the earlier pregnancy weeks.
- 31 December 2020
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 17 (4) , 580-584
Pregnancy Outcomes After Emergency Cerclage For Cervical Insufficiency A Retrospective Study
Aim: Evaluation of maternal and fetal outcomes, effectiveness and reliability of the cerclage for the emergently cerclaged cases due to cervical insufficiency Materials and Methods: Clinical data from live singleton pregnancies who were diagnosed cervical insufficiency were reviewed retrospectively between the Feb 2010-Jan 2019, at Acıbadem University and Mersin University, Department of Obstetrics and Gynecology. Results: During the study period, total 29 cervical cerclage operation was performed by McDonald technique. Mean maternal age 31.82±4.449 years (21–38), mean gestational age at diagnosis and cerclage placement was 22.17±2.071 weeks (18-28). Take home baby rate was 79.3 % (n=23). Mean time interval between the cerclage and the birth is 9.24±5.723 weeks (0-18), mean pregnancy week during the birth is 31.4±5.02 weeks (23-39) and mean birth weight is 1873±903 g (650-3782). There was no surgical complication reported from the studied population. Thirty percent (9) of the patients were delivered by C-section. Discussion: Emergency cerclage prolongs the pregnancy duration of the women with cervical insufficiency, and has marked effects on improving the neonatal outcomes. It is thought to be an appropriate choice for the women with cervical dilatation at the earlier pregnancy weeks.